Lilly suspends small studies of pipeline drug prasugrel
October 25 2007
Eli Lilly said it is suspending two small studies of its most promising pipeline candidate, the blood-thinner prasugrel, after data ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.